Levels of TNF, TNF autoantibodies and soluble TNF receptors in patients with bronchial asthma

References

• Robak T, Gladalska A, Stepiec H. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis. Eur Cytokine Netw 1998;9:145–54
   PubMed Web of Science ®Google Scholar
• Berry M, Brightling C, Pavord I, Wardlaw AJ. TNF-α in asthma. Curr Opin Pharmacol 2007;7:279–82
   PubMed Web of Science ®Google Scholar
• Adner M, Rose AC, Zhang Y, et al. An assay to evaluate the longterm effects of inflammatory mediators on murine airway smooth muscle: evidence that TNFalpha up-regulates 5-HT(2A)-mediated contraction. Br J Pharmacol 2002;137:971–82
   PubMed Web of Science ®Google Scholar
• Huber M, Beutler B, Keppler D. Tumor necrosis factor alpha stimulates leukotriene production in vivo. Eur J Immunol 1988;18:2085–8
   PubMed Web of Science ®Google Scholar
• van Overveld FJ, Jorens PG, Rampart M, et al. Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase. Clin Exp Allergy 1991;21:711–4
   PubMed Web of Science ®Google Scholar
• Coward WR, Okayama Y, Sagara H, et al. NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells? J Immunol 2002;169:5287–93
   PubMedGoogle Scholar
• Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995;152:76–80
   Google Scholar
• Thomas PS, Heywood G. Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax 2002;57:774–8
   PubMed Web of Science ®Google Scholar
• Kohno T, Brewer MT, Baker SL, et al. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 1990;87:8331–5
   PubMed Web of Science ®Google Scholar
• Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994;76:959–62
   PubMed Web of Science ®Google Scholar
• Yoshida S, Hashimoto S, Nakayama T, et al. Elevation of serum soluble tumour necrosis factor (TNF) receptor and IL-1 receptor antagonist levels in bronchial asthma. Clin Exp Immunol 1996;106:73–8
   PubMed Web of Science ®Google Scholar
• Fomsgaard A, Svenson M, Bendtzen K. Auto-antibodies to tumour necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections. Scand J Immunol 1989;30:219–23
   PubMedGoogle Scholar
• Bendtzen K, Hansen MB, Ross C, Svenson M. Detection of autoantibodies to cytokines. Mol Biotechnol 2000;14:251–61
   PubMedGoogle Scholar
• Wadhwa M, Meager A, Dilger P, et al. Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations. Immunology 2000;99:113–23
   PubMed Web of Science ®Google Scholar
• Watanabe M, Uchida K, Nakagaki K, et al. Anti-cytokine autoantibodies are ubiquitous in healthy individuals. FEBS Lett 2007;581:2017–21
   PubMed Web of Science ®Google Scholar
• Watanabe M, Kanji U, Kazuhide N, et al. High avidity cytokine autoantibodies in health and disease: Pathogenesis and mechanisms. Cytokine Growth Factor Rev 2010;21:263–73
   PubMed Web of Science ®Google Scholar
• Global treatment and asthma prevention strategy, revision of 2011. Translated from English. M. Russian Respiratory Society, 2012
   Google Scholar
• Gosset P, Tsicopoulos A, Wallaert B, et al. Increased secretion of tumor necrosis factor α and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol 1991;88:561–71
   PubMed Web of Science ®Google Scholar
• Gosset P, Tsicopulos A, Wallaert B, et al. Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. Am J Respir Dis 1992;146:768–74
   PubMedGoogle Scholar
• Ying S, Robinson DS, Varney V, et al. TNF alpha mRNA expression in allergic inflammation. Clin Exp Allergy 1991;21:745–50
   PubMed Web of Science ®Google Scholar
• Klimiuk PA, Sierakowski S, Latosiewicz R, et al. Circulating tumour necrosis factor alpha and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis. Ann Rheum Dis 2003;62:472–5
   PubMedGoogle Scholar
• Krichevskaya OA, Kljukvin NG, Aleksandrova E. Tumor necrosis factor α and its soluble receptors in rheumatic diseases: clinical and pathogenetic significance. Scientific-Practical rheumatology (Russian) 2005;2:43–6
   Google Scholar
• Pennica D, Lam VT, Mize NK, et al. Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylation. J Biol Chem 1992;267:21172–8
   Google Scholar
• Meager A, Wadhwa M, Bird C, et al. Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease. Immunology 1999;97:526–32
   PubMed Web of Science ®Google Scholar
• Meager A, Wadhwa M, Dilger P, et al. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis. Clin Exp Immunol 2003;132:128–36
   PubMed Web of Science ®Google Scholar
• Puel A, Döffinger R, Natividad A, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010;15:291–7
   Google Scholar
• Sennikov SV, Golikova EA, Kiree FD, Lopatnikova JA. Purification of human immunoglobulin G autoantibodies to tumor necrosis factor using affinity chromatography and magnetic separation. J Immunol Methods 2013;390:92–8
   Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;15:680–5
   Google Scholar
• Yount WJ, Cohen P, Eisenberg RA. Distribution of IgG subclasses among human autoantibodies to Sm, RNP, dsDNA, SS-B and IgG rheumatoid factor. Monogr Allergy 1988;23:41–56
   Google Scholar
• Maran R, Dueymes M, Le Corre R, et al. IgG subclasses of human autoantibodies. Ann Med Interne (Paris) 1997;148:29–38
   Google Scholar
• Cook AD, Mackay IR, Cicuttini FM, Rowley MJ. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 1997;24:2090–6
   PubMedGoogle Scholar
• Furukawa K, Kobata A. IgG galactosylation – its biological significance and pathology. Mol Immunol 1991;28:1333–40
   Google Scholar
• van Loghem E. Allotypic markers. Monogr Allergy 1986;19:40–51
   Google Scholar